SCHEMBL22018149

SCHEMBL22018149

O=C(Nc1cnc2ccsc2c1C1CCCCCCCC1)c1ccccccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ADCY1 Q08828 2/20 0.46
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SCD O00767 1/20 0.42
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PKM P14618 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CDK5 Q00535 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HDAC1 Q13547 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
TRPV1 Q8NER1 1/20 0.39
ADCY8 P40145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22138702 0.84 PIK3CA (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL18399540 0.83 RAB9A (0.49) NPC1RAB9AKMT2ASMN1; SMN2HDAC1
SCHEMBL19059709 0.83 RAB9A (0.49) NPC1RAB9AKMT2ASMN1; SMN2HDAC1
SCHEMBL18399536 0.83 RAB9A (0.49) NPC1RAB9AKMT2ASMN1; SMN2HDAC1
SCHEMBL19059706 0.83 RAB9A (0.49) NPC1RAB9AKMT2ASMN1; SMN2HDAC1
SCHEMBL22018420 0.82 KDM4E (0.50) KDM4EADCY1NPC1RAB9ASCD
SCHEMBL18399529 0.81 MALT1 (0.52) KDM4EADCY1L3MBTL1TRPV1
SCHEMBL21157772 0.78 ADCY1 (0.44) KDM4EADCY1NPC1RAB9ACDK2
SCHEMBL18399571 0.75 ADCY1 (0.46) KDM4EADCY1NPC1RAB9ASMN1; SMN2
SCHEMBL18399586 0.74 PARP1 (0.47) KDM4EADCY1NPC1RAB9ACCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors INCYTE CORPORATION (US) 2020-11-10 US disclosed
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS INCYTE HOLDINGS CORPORATION 2020-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200155527-A1 THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS PIM2, PIM1, PIM3 KDM4E 913/4885ADCY1 1867/4885NPC1 2615/4885
US-10828290-B2 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors PIM2, PIM1, PIM3 KDM4E 913/4885ADCY1 1867/4885NPC1 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.